Download presentation
Presentation is loading. Please wait.
Published byDella James Modified over 9 years ago
1
Pak - Demographics Population150 mn Pop. Growth Rate1.9% Urban33% Crude Birth Rate27.8 / 1000 Crude Death Rate7.2/ 1000
2
Health Budgets
3
Health Facilities Doctors 1,1635 Dentists 5,068 Nurses 44520 Doctor /100,000 pop 70.16 Dentist / 100,000 pop 3.49 Nurse /100,000 pop 30.73
4
Health Facilities Hospitals 907 Dispensaries 4,625 No of beds 97,945 Pop per bed 1,490
5
Infectious Serology 30-40% IVD Market (Pakistan) Routine Chemistry 30-40% Special Chemistry 15-20% Others 5-10% IVD Market in Pakistan
6
Provincial Govt. (20%) Private(40%) Pakistan (Total IVD) Govt.(60%) Armed Forces (25%) Federal Govt. (15%)
7
Army (8-10) 7% Air Force (3) 2% Navy (2) 3% Fouji Foundation (6-8) 5% Nuclear Institute (10) 8% Armed Forces (25%) Only A Class Hospital (>300 Beds) have been taken.
8
Teaching Hospitals (12) Dist. Hospitals >80 Provincial Govt. (20%)
9
Federal Govt. (15%) PIMS, Islamabad FGSH, Islamabad Sh. Zaid, Lahore
10
Private 40% GCC Centers (26) 50% Agha Khan 10% Husaini Blood Bank 10% Others 30%
11
Predictions of Lord Kelvin, president of the Royal Society, 1890-95 "Radio has no future" "Heavier than air flying machines are impossible" "X rays will prove to be a hoax”
12
In trouble some people grow wings; others buy crutches Harold W. Ruoff
13
Strategic Intent Among the top 03 Pak Diag.by 2005
14
Mission Supply IVD to our valued customers at affordable prices without sacrificing services, speed and reliability.
15
History Founded in September 2000
16
GMS-World Global Marketing Services, Pakistan (September 2000) Global Biotech, Pvt. Ltd. (July 2005) For biological products Global Linx UK (June 2005) For export of surgical products GMS, UAE (June 2003) A trading & distribution hub Global Biotech, Inc. USA (Feb 2005) R & D, molecular biology products
17
Capabilities Partnering Marketing Distribution (Network) After Sale Services (Engineering Setup)
18
Products Portfolio Partnerships Total solution Products Services
19
Products Portfolio Immuno-chemistry Chemical Pathology Blood Bank and hematology Micro Biology Molecular Biology
20
Organization Chart How we organize?
21
CEO / President Zafar Mahmood Director Operations Dr. Syed Uzair-ul-Ghani Director Finance & Administration Muhammad Ayub Business Manager GM Technical Services Managers Distribution Accounts Store
22
Organization Chart How we organize? HUMAN RESOURCE Qualification Department Total MarketingR&D/Production Financ ePersonnelIT PhD 21--- 3 M.Phil 2---- 2 Post ICMA --1-- 1 Graduates (MBA) 6-1-1 8 Graduate (MCS) ----1 1 Graduates Biomedical Engineer 43--- 7 Technicians 83--- 11 Workers 63210- 21 Total 28104 254
23
Distribution PUNJAB Islamabad Rawalpindi Lahore Faisalabad Multan Sargodha BALOCHISTAN SINDH N.W.F.P Peshawar Swat AJ & K Muzaffarabad Karachi Hyderabad Quetta
24
How we evolved ? Year 20002001200220032004 Staff 410354550 Revenue (Rs in mn) 1225 60 100150 Dist. Offices 24810 Principals 2615>20
26
Sales Rs in mns
27
UAE Labanan KuwaitIraq Saudi Arabia MasqatIran Oman Syria +Jordon
28
Participation in Exhibit. / Conf. PAP 2001 Arab Lab 2003 Pak Haemat. 2002 Pak Diabetic 2002
29
Promo 2004 Seminars (Foreign Speakers) Cepheid 07 Awareness 02 Foreign Principals Visit 10
30
Promo 2004 Round Table >100 Molecular Biology Infertility liver diseases Diabetes
31
Cust. contact in seminars 300 RTD’s 1000 Consultants for int. conf. 10 Sponsored conf in Pak 03 Promo 2004
32
Pakistan Association of Pathologist 2004 at PIMS Islamabad GMS act as Major Contributor
33
HUSSAINI BLOOD BANK International Conference on SAFE BLOOD Transfusion at AVARI Tower Karachi 17-Dec-2004 to 18-Dec-2004 Delegates visited from Sri Lanka, India, New Zealand, Maldives, Nepal & USA
34
Event: ARAB LAB 2005 Venue: Dubai Trade Center DUBAI Dates: Jan 31 st – Feb 03 2005
35
Foreign trainings GMS 05 Local Tech Training 12 Dealers Sales training 03 Trainings 2004
36
Customers Base 1000 Teaching Hospitals Army 35 CMH Public Civil Private Research institutes
37
Coverage The only company having Pan Pakistan dealing customers directly having after sale network in major cities
38
R&D Pak, syringe reuse 70% To avoid we developed SYRINGE BURNNER Strategic partnership for AD syringe
40
Press Coverage
41
Societal role
42
Anti Hepatitis Campaign March 2000 Awareness Screening Facilities Vaccination Programs
43
Hussaini Haematology & Oncology Trust, Karachi 1.Awareness 2. Prevalence testing 3.Prevention Thalassemia care Campaign
44
1.Extending PCR facilities to door step. 2.PIONEER IN PCR (1995) NIBGE
45
Low cost Hepatitis testing Chemical Path tests PRCS Diagnostic facilities
46
Strengths Strategic alliance Team of 50 professionals Pan Pak distribution and marketing network
47
After sale services Placement on reagent rental 12 clinical chem. auto. systems 300 photometers 100 (Semi Automated EIA System) Strengths
48
Strength Partnering with PRCS Partnering Thalassamia Society Hussaini Trust
49
Continuous training for Marketing Technical staff Sub dealers MIS Regular Participation in local exhibition, conferences Strength
50
The difference between ordinary and extraordinary is that little extra Zig Ziglar
51
It is always better to fail in doing something than to excel in doing nothing
52
Thank You !
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.